Company news
CNBX Pharmaceuticals Inc. news in 2018
CNBX Pharmaceuticals Inc.'s news releases, calls and decks from 2018, newest first.
Cannabics Pharmaceuticals to be present during the J.P. Morgan Healthcare Conference In San Francisco
December 31, 2018
Cannabics Pharmaceuticals Announces New Provisional Patent Application for Personalized Cannabimetic Compositions Modeling and Production
December 26, 2018
Cannabics Pharmaceuticals Prepares ISO Application for Its Diagnostics Platform Towards Commercialization
December 11, 2018
Cannabics Pharmaceuticals Announces New Provisional Patent Application for Magnetic Targeting of Cannabinoids
November 28, 2018
CEO of Cannabics Pharmaceuticals Presenting at 11th Annual LD Micro Conference, on December 5th, 2018 in LA, California
November 27, 2018
Cannabics Pharmaceuticals Inc. CEO talks with Uptick Newswire’s Stock Day Podcast About Cancer Research in the Cannabinoid Sector
November 6, 2018
CEO of Cannabics Pharmaceutical Speaking at MJBizCon 2018 in Las Vegas
November 1, 2018
Cannabics Pharmaceuticals Granted Patent in South Africa for Its Personalized Cannabinoid Based Diagnostics
October 25, 2018
Cannabics Pharmaceuticals Announces Attendance at the CannMed 2018 Conference, Held at the UCLA Luskin Conference Center, Los Angeles, October 22-24
October 19, 2018
Cannabics Pharmaceuticals Announces Positive Results for Pilot Study on Treatment of Cancer Anorexia-Cachexia Syndrome (CACS)
October 16, 2018
Join Cannabics Pharmaceuticals at the 3rd CannX Medical Cannabis Conference, Held at Tel-Aviv Convention Center, Israel, October 14-16, 2018
October 9, 2018
Cannabics Pharmaceuticals Inc. Prices $7,500,000 Registered Direct Offering
September 24, 2018
Cannabics Pharmaceuticals to Present Results of Clinical Trial at International Medical Cannabis Conference
September 21, 2018
Eroll Grow Tech (Seedo) Merges Its Activities With GRCR Partners; Cannabics Pharmaceuticals to Own 13.6% in the Merged Company
September 18, 2018
Cannabics Pharmaceuticals Receives Positive Results in the Development of Cannabinoid-anticancer Drugs
September 14, 2018
Cannabics Pharmaceuticals Granted Patent in Israel for Its Core Technology for Personalized Cannabinoid Based Medicine
September 5, 2018
Cannabics Pharmaceuticals Inc. Appoints Dr. Estery Giloz-Ran to Its Advisory Board
August 28, 2018
Cannabics Pharmaceuticals Announces That Seedo is to End Pre-Sales and Commence Delivery of Its Automated Growing Devices
August 22, 2018
Cannabics Pharmaceuticals Partners with Eroll Grow Tech to Create First Auto-Grow Device for Medical Cannabis
August 14, 2018
Cannabics Pharmaceuticals Announces Attendance at the Benzinga Cannabis Capital Conference
August 10, 2018
Join Cannabics Pharmaceuticals at the MJBizCon Held at Metro Toronto Convention Center, Toronto, August 14-16, 2018
August 9, 2018
Cannabics Pharmaceuticals' CEO Issues Letter to Shareholders
August 2, 2018
Join Cannabics Pharmaceuticals at the National Cannabis Industry Association's Cannabis Business Summit and Expo Held at San Jose Convention Center, California USA, July 25-27, 2018
July 11, 2018
Cannabics Pharmaceuticals Announces Conclusion of Clinical Trial on Cannabics SR 5mg for Cancer Anorexia Cachexia Syndrome (CACS)
July 3, 2018
Cannabics Pharmaceuticals Enters a Memorandum of Understanding With Clinical-Stage Biopharmaceutical Company Focused on the Treatment of Ophthalmic Disorders
June 29, 2018
Cannabics Pharmaceuticals to Participate in the International Cannabis Research Society Annual Forum in Leiden, the Netherlands
June 26, 2018
Join Cannabics Pharmaceuticals at LCBC Cannabis Professional Conference Held at MTCC, Toronto, Canada, May 25-27, 2018
May 24, 2018
Cannabics Pharmaceuticals Hires Two New Scientists to Further Develop Cannabinoid Diagnostic Tests and Treatments for Cancer
May 22, 2018
Cannabics Pharmaceuticals Announces Collaboration With Life Source Partners CEO Muriel Zohar to Optimize Technology Applications and Evaluate New Opportunities
May 2, 2018
Cannabics Pharmaceuticals Announces New Technology Patent
April 18, 2018
Cannabics Pharmaceuticals Receives Positive Results From Preclinical Study on Antitumor Effects of Cannabinoids
March 29, 2018
Cannabics' Dr. Moran Grinberg to Speak at the Annual CannaTech Conference
February 28, 2018
Cannabics Pharmaceuticals Hires Chief Data Officer to Address Industry Compliance and Utilization/Analytics Application
February 20, 2018
Cannabics Pharmaceuticals Files an International Patent Application on Methods for Testing and Predicting Therapeutic Effectiveness of Cannabinoids for Cancer Patients
January 2, 2018